Pharmalucence, Inc.

FDA Regulatory Profile

Pharmalucence, Inc. appears in FDA public data with 3 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1040-2018, Class II) was initiated on June 6, 2018.

Summary

Total Recalls
3
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1040-2018Class IIKit for the Preparation of Technetium Tc99m Medronate, 20mg in 10 mL vial, packaged in a) 5-count boJune 6, 2018
D-0815-2018Class IIKit for the Preparation of Technetium TC-99M Mebrofenin, 45 mg in 10 mL (5 count), NDC 45567-0455-1 April 10, 2018
D-808-2013Class IIIPharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and BreMay 30, 2013